Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(1992): Bodokh I+, Presse Med (French) 21, 630
(1991): Hertzberger-ten-Cate R+, Clin Exp Rheumatol 9, 85
(1990): Donovan S+, Br J Rheumatol 29, 201 (4.1%)
(1990): Gupta AK+, Arch Dermatol 126, 487 (23%)
(1990): Petterson T+, Br J Rheumatol 29, 239
(1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223
(1989): Gremse DA+, J Pediatr Gastroenterol Nutr 9, 261
(1988): Williams HJ+, Arthritis Rheum 31, 702 (7%)
(1986): Farr M+, Drugs 32 (Suppl 1), 49
(1986): Poland GA+, Am J Med 81, 707
(1985): Maayan S+, Arch Intern Med 145, 1607
(1984): Iwatsuki K+, Arch Dermatol 120, 964
(1984): Peppercorn MA, AnnInternMed101, 377
(1984): Purdy BH+, AnnInternMed100, 512
(1982): Goetz MB+, JAMA 247, 3118
(1980): Fennell RS+, Clin Pediatr 19, 124
Exfoliative dermatitis
(1990): Donovan S+, Br J Rheumatol 29, 201
(1984): Sala F+, Cronica Dermatol (Italian) 15, 209
Fixed eruption
(1996): Kawada A+, Contact Dermatitis 34, 155
(1988): Bharija SC+, Dermatologica 176, 108
(1987): Hughes BR+, Br J Dermatol 116, 241
(1987): Kanwar AJ+, Dermatologica 174, 104
(1986): Kanwar AJ+, Dermatologica 172, 230
(1982): Gibson JR, BMJ 284, 1529
(1980): Talbot MD, Practitioner 224, 823
Lichen planus
(1995): Kaplan S+, J Rheumatol 22, 191
(1991): Alstead EM+, J Clin Gastroenterol 13, 335
Lupus erythematosus
(2002): Angelova I+, World Congress Dermatol Poster, 0083
(patient has psoriasis)
(2002): Siddiqui MA+, Am J Ther 9(2), 163 (passim)
(2002): Tsai WC+, Clin Rheumatol 21(4), 339
(2000): Chebli JM+, Arq Gastroenterol 37(4), 224
(2000): Gunnarsson I+, Rheumatology (Oxford) 39(8), 886
(1997): Gunnarsson I+, Br J Rheumatol 36, 1089
(1996): Khattak FH+, Br J Rheumatol 35, 104
(1995): Veale DJ+, Br J Rheumatol 34, 383
(1994): Borg AA+, Clin Rheumatol 13, 522
(1994): Bray VJ+, J Rheumatol 21, 2157
(1994): Caulier M+, J Rheumatol 21, 750
(1994): Fritzler MJ, Lupus 3, 455
(1994): Mongey AB+, Br J Rheumatol 33, 789
(1994): Walker EM+, Br J Rheumatol 33, 175
(1993): Siam AR+, J Rheumatol 20, 207
(1993): Wildhagen K+, Clin Rheumatol 12, 265
(1992): Skaer TL, Clin Ther 14, 496
(1991): Alarcon-Segovia D+, Baillieres Clin Rheumatol 5, 1
(1989): Deboever G+, Am J Gastroenterol 84, 85
(1989): Sugimoto M+, Nippon Naika Gakkai Zasshi (Japanese)
78, 583
(1988): Clementz GL+, Am J Med 84, 535
(1987): Hobbs RN+, Ann Rheum Dis 46, 408
(1985): Lovisetto P+, Recenti Prog Med (Italian) 76, 110
(1985): Stratton MA, Clin Pharm 4, 657
(1983): Vanheule BA+, Eur J Pediatr 140, 66
(1982): Carr-Locke DL, Am J Gastroenterol 77, 614
(1980): Crisp AJ+, JRSocMed73, 60
(1980): Rouleau L+, Union Med Can (French) 109, 1326
Necrosis
(1988): Krakamp B+, Med Klin (German) 83, 611
Photosensitivity (10%)
(2006): Duparc A+, Presse Med 35(7–8), 1138
(1999): Bouyssou-Gauthier ML, Dermatology 198, 388
(1994): Shelley WB+, Cutis 53, 240 (observation)
(1986): Amos RS+, BMJ 293, 420 (1–5%)
(1986): Chandler MJ, JInfectDis153, 1001
Pigmentation
SULFASALAZINE 513
(1992): Gabazza EC+, Am J Gastroenterol 87, 1654 (orangeyellow)
Pruritus (10%)
(1993): Gran JT+, Scand J Rheumatol 22, 229
(1990): Donovan S+, Br J Rheumatol 29, 201
(1990): Peppercorn MA, AnnInternMed112, 50 (1–5%)
(1987): Colebunders R+, AnnInternMed107, 599
(1986): Farr M+, Drugs 32 (Suppl 1), 49
(1986): Sher MR, J Allergy Clin Immunol 77, 133
(1984): Kramer BS+, Cancer 53, 329
Pruritus ani et vulvae
(1981): Modern Medicine 49, 111
Psoriasis
(1991): Bliddal H+, Clin Rheumatol 10, 178
Purpura
(1989): Gremse DA+, J Pediatr Gastroenterol Nutr 9, 261
Pustules
(1994): Gallais V+, Ann Dermatol Venereol (French) 121, 11
Rash (sic) (>10%)
(2003): Fischetti F+, Minerva Med 94(6), 437
(2000): Jung JH+, Clin Exp Rheumatol 18, 245
(1999): Besnard M+, Arch Pediatr 6, 643
(1994): McCarthy C+, Ir J Med Sci 163, 238
(1993): Koski JM, Clin Exp Dermatol 11, 169
(1992): Brooks H+, Clin Rheumatol 11, 566
(1992): Giaffer MH+, Aliment Pharmacol Ther 6, 51 (10 cases) )
(1989): Gyssens IC+, Ned Tijdschr Geneeskd (Dutch) 133, 1608
(1989): Scott DL+, J Rheumatol Suppl 16, 17
(1986): Bax DE+, Ann Rheum Dis 45, 139
(1984): Farr M+, Clin Rheumatol 3, 473
(1984): Purdy BH+, AnnInternMed100, 512
Raynaud’s phenomenon
(1984): Ahmad J+, J Assoc Physicians India 32(4), 370
(1984): Peppercorn MA, AnnInternMed101, 377
(1980): Reid J+, Postgraduate Med J 56, 106
Side effects (sic) (5%)
(1986): Amos RS+, BMJ 293, 420 (5.5%)
Stevens–Johnson syndrome (